Regeneron Pharmaceuticals REGN TD Cowen Ups Price Target Ahead of Fiscal Q1 Results Supported by FDA Gene Therapy Approval Texas Instruments Incorporated TXN Analysts Lift Price Targets Following Robust Q1 2026 Performance and BroadBased Demand Growth MillerKnoll MLKN Stock Is It Losing Strength MillerKnoll posts 63 EPS miss vs analyst targets